BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 20670477)

  • 21. [Identification of acute leukemia-specific genes from leukemia recipient/sibling donor pairs by distinguishing study with oligonucleotide microarrays].
    Sun Y; Dong LJ; Tian F; Wang SQ; Jia ZL; Huang J; Chen ZJ; Li WJ; Chen XL; Zhu P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Aug; 12(4):450-4. PubMed ID: 15363129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of Leukocytic Syncytin-1 in Acute Myeloid Leukemia Patients.
    Sun Y; Zhu H; Song J; Jiang Y; Ouyang H; Huang R; Zhang G; Fan X; Tao R; Jiang J; Niu H
    Med Sci Monit; 2016 Jul; 22():2392-403. PubMed ID: 27393911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring of WT-1 gene expression in peripheral blood of patients with acute leukemia by semiquantitative RT-PCR; possible marker for detection of minimal residual leukemia.
    Kim SC; Yoo NC; Hahn JS; Lee S; Chong SY; Min YH; Ko YW
    Yonsei Med J; 1997 Aug; 38(4):212-9. PubMed ID: 9339129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: choice of technique and purification influence the identification of potential diagnostic markers.
    Staal FJ; van der Burg M; Wessels LF; Barendregt BH; Baert MR; van den Burg CM; van Huffel C; Langerak AW; van der Velden VH; Reinders MJ; van Dongen JJ
    Leukemia; 2003 Jul; 17(7):1324-32. PubMed ID: 12835720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinction of acute lymphoblastic leukemia from acute myeloid leukemia through microarray-based DNA methylation analysis.
    Scholz C; Nimmrich I; Burger M; Becker E; Dörken B; Ludwig WD; Maier S
    Ann Hematol; 2005 Apr; 84(4):236-44. PubMed ID: 15538567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BAALC-associated gene expression profiles define IGFBP7 as a novel molecular marker in acute leukemia.
    Heesch S; Schlee C; Neumann M; Stroux A; Kühnl A; Schwartz S; Haferlach T; Goekbuget N; Hoelzer D; Thiel E; Hofmann WK; Baldus CD
    Leukemia; 2010 Aug; 24(8):1429-36. PubMed ID: 20535151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clathrin assembly lymphoid myeloid leukemia-AF10-positive acute leukemias: a report of 2 cases with a review of the literature.
    Huh JY; Chung S; Oh D; Kang MS; Eom HS; Cho EH; Han MH; Kong SY
    Korean J Lab Med; 2010 Apr; 30(2):117-21. PubMed ID: 20445327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of H3K27 methylation identifies poor outcomes in adult-onset acute leukemia.
    van Dijk AD; Hoff FW; Qiu YH; Chandra J; Jabbour E; de Bont ESJM; Horton TM; Kornblau SM
    Clin Epigenetics; 2021 Jan; 13(1):21. PubMed ID: 33509276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential chemosensitivity of leukemic cells in the myeloid and lymphoid phases of stem cell leukemia (a case report).
    Mihál V; Hajdúch M; Dusek J; Jarosová M; Weigl E; Pikalová Z; Indrák K; Safárová M; Janostáková A
    Neoplasma; 1997; 44(2):133-6. PubMed ID: 9201294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current status of gene expression profiling in the diagnosis and management of acute leukaemia.
    Bacher U; Kohlmann A; Haferlach T
    Br J Haematol; 2009 Jun; 145(5):555-68. PubMed ID: 19344393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characterization of acute leukemias by use of microarray technology.
    Kohlmann A; Schoch C; Schnittger S; Dugas M; Hiddemann W; Kern W; Haferlach T
    Genes Chromosomes Cancer; 2003 Aug; 37(4):396-405. PubMed ID: 12800151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Detection of the expression of NK ligands in acute leukemia cell lines by real-time PCR].
    Luo Y; Duan LN; Lu CR; Cai Q; Wang Z; Bao RF; Xiang PD
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jan; 34(1):26-9. PubMed ID: 23597460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of fusion gene--integral part of the assessment of children with acute leukemia].
    Miron I; Ivanov A; Ivanov I; Dumitraş S
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):731-5. PubMed ID: 22046779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The overexpression of KIT proto-oncogene in acute leukemic cells is not necessarily caused by the gene mutation.
    Szatkowski D; Hellmann A
    Acta Haematol; 2015; 133(1):116-23. PubMed ID: 25247397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High expression of inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia.
    Shi JL; Fu L; Wang WD
    Oncotarget; 2015 Mar; 6(7):5299-309. PubMed ID: 25779662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NPM1 alternative transcripts are upregulated in acute myeloid and lymphoblastic leukemia and their expression level affects patient outcome.
    Handschuh L; Wojciechowski P; Kazmierczak M; Marcinkowska-Swojak M; Luczak M; Lewandowski K; Komarnicki M; Blazewicz J; Figlerowicz M; Kozlowski P
    J Transl Med; 2018 Aug; 16(1):232. PubMed ID: 30126426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pro-inflammatory cytokines and depression in patients with acute leukemia.
    El-Gohary GM; Azzam HM; Ahmed OI; El-Shokry MH
    Egypt J Immunol; 2008; 15(1):13-24. PubMed ID: 20306666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PRAME mRNA levels in cases with acute leukemia: clinical importance and future prospects.
    Paydas S; Tanriverdi K; Yavuz S; Disel U; Baslamisli F; Burgut R
    Am J Hematol; 2005 Aug; 79(4):257-61. PubMed ID: 16044453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular biology strategies to detect residual disease.
    Garcés-Eisele J
    Hematology; 2012 Apr; 17 Suppl 1():S66-8. PubMed ID: 22507783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.